Target |
Mechanism FSHR agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date27 Apr 2021 |
Target |
Mechanism LHCGR agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date02 Mar 2009 |
Target |
Mechanism LHCGR agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date29 Aug 2001 |
Start Date15 Sep 2024 |
Sponsor / Collaborator- |
Start Date01 Sep 2024 |
Sponsor / Collaborator |
Start Date12 Aug 2024 |
Sponsor / Collaborator |